Basti and Rasayan for Post COVID-19 Syndrome

Clinical Evaluation of Basti along with Rasayana on symptoms of Post COVID-19 Syndrome.Open Labelled Proof of Concept Pragmatic Study.

Status

Active, not recruiting

Phases

Phase 2Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2021/08/035732

Enrollment

Registered

2021-08-17

Start date

Unknown

Completion date

Unknown

Last updated

2024-03-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: B972- Coronavirus as the cause of diseases classified elsewhere Health Condition 2: B342- Coronavirus infection, unspecified

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: • Patients of Post COVID-19 Syndrome came under duration of >21 days to 1 year after RTPCR report • Patient of either sex aged between 18-70 years. irrespective of caste, religion , socio economic and educational status. • Patient of Post COVID-19 Syndrome having > 20 % ( > 4) of symptoms will be included for the study. • Patient of Post COVID-19 Syndrome who are willing to participate in trial and ready to give written consent.

Exclusion criteria

Exclusion criteria: • Patients with serious lifethreatening diseases and critically ill patients of Post COVID-19 Syndrome will be excluded. • Pregnant females and lactating mothers will not be considered for study. • Basti Anarhya will be excluded for study. • Patient who have known hypersensitivity reactions to medicines mentioned in the study will be excluded. • Any other patient which investigator feels not to be included will be excluded from study.

Design outcomes

Primary

Measure	Time frame
1.To evaluate the efficacy of Triphala Kwath Niruh Basti, Tiltail Anuvasan Basti and Brahma Rasayana on symptoms of Santarpanottha Post COVID-19 Syndrome in period of 35 days. 2. To evaluate the efficacy of Brihatpanchmulsidhha Kshirbasti ,Kshirbala tail Anuvasan Basti and Kalyanak Ghrit on symptoms Apatarpanottha Post COVID-19 Syndrome period of 35 days. 3. To compare symptoms of Santarpanottha and Apatarpanottha Post COVID-19 Syndrome at the time of recruitment. Timepoint: 18 month	—

Measure

Time frame

1.To evaluate the efficacy of Triphala Kwath Niruh Basti, Tiltail Anuvasan Basti and Brahma Rasayana on symptoms of Santarpanottha Post COVID-19 Syndrome in period of 35 days. 2. To evaluate the efficacy of Brihatpanchmulsidhha Kshirbasti ,Kshirbala tail Anuvasan Basti and Kalyanak Ghrit on symptoms Apatarpanottha Post COVID-19 Syndrome period of 35 days. 3. To compare symptoms of Santarpanottha and Apatarpanottha Post COVID-19 Syndrome at the time of recruitment. Timepoint: 18 month

—

Secondary

Measure	Time frame
To review the Ayurvedic Concepts of Post COVID-19 syndrome.Timepoint: 18 month	—

Countries

India

Contacts

Public ContactPayal Rathod

Government Ayurved College,Nagpur

amitnakanekar@gmail.com9850233016

Outcome results